Browsing Centre for Preventative Neurology by Title
Now showing items 53-72 of 156
-
Gene-Environment Interactions for Parkinson's Disease.
(2023-12-19)OBJECTIVE: Parkinson's disease (PD) is a neurodegenerative disorder with complex etiology. Multiple genetic and environmental factors have been associated with PD, but most PD risk remains unexplained. The aim of this study ... -
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
(2020-01-01)Parkinson's disease is a genetically complex disorder. Multiple genes have been shown to contribute to the risk of Parkinson's disease, and currently 90 independent risk variants have been identified by genome-wide association ... -
Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts
(2019-08-01)Copyright © 2019 The Author(s). Objective To determine if any association between previously identified alleles that confer risk for Parkinson disease and variables measuring disease progression. Methods We evaluated the ... -
Hearing and dementia
(2016-11) -
Identification of prodromal Parkinson's Disease - we may be able to but should we?
(Lippincott, Williams & Wilkins, 17-05-2024)Parkinson disease (PD) remains a progressive and incurable disease. Research over the past decade provides strong evidence of a detectible phase before the clinical diagnosis, known as the prodromal phase of PD (pPD). ... -
Impact and experiences of vestibular disorders and psychological distress: Qualitative findings from patients, family members and healthcare professionals.
(2023-11-01)INTRODUCTION: People with vestibular disorders frequently experience reduced quality of life and challenges with activities of daily living. Anxiety, depression and cognitive problems often co-present with vestibular ... -
The Impact of COVID-19 on Access to Parkinson's Disease Medication.
(2020-08-28)BACKGROUND: Many countries have implemented drastic measures to fight the COVID-19 pandemic. Restrictions and diversion of resources may have negatively affected patients with Parkinson's disease (PD). Our aim was to examine ... -
The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multi-Methods Study
(Consortium of Multiple Sclerosis Centers, 2024-01-22) -
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
(2024-03-07)BACKGROUND: Aquaporin-4 (AQP4) antibody associated neuromyelitis optica (NMOSD) requires long-term immunosuppression. Rituximab is increasingly used worldwide, however the optimal regime is not established. METHODS: We ... -
Improving estimation of Parkinson's disease risk - The enhanced PREDICT-PD algorithm
(2020-03-23)medRxiv preprint